BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9115927)

  • 1. Drug-induced linear IgA disease: target antigens are heterogeneous.
    Paul C; Wolkenstein P; Prost C; Caux F; Rostoker G; Heller M; Wechsler J; Revuz J; Roujeau JC
    Br J Dermatol; 1997 Mar; 136(3):406-11. PubMed ID: 9115927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.
    Armstrong AW; Fazeli A; Yeh SW; Mackool BT; Liu V
    J Cutan Pathol; 2004 May; 31(5):393-7. PubMed ID: 15059226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting.
    Zhou S; Ferguson DJ; Allen J; Wojnarowska F
    Br J Dermatol; 1998 Oct; 139(4):591-7. PubMed ID: 9892901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane.
    Gabrielsen TO; Staerfelt F; Thune PO
    Acta Derm Venereol; 1981; 61(5):439-41. PubMed ID: 6172936
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies.
    Hashimoto T; Ishiko A; Shimizu H; Tanaka T; Dodd HJ; Bhogal BS; Black MM; Nishikawa T
    Br J Dermatol; 1996 Feb; 134(2):336-9. PubMed ID: 8746352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic bullous disease with coexistent circulating IgG and IgA anti-basement membrane zone antibodies.
    Miyagawa S; Kiriyama Y; Shirai T; Ohi H; Sakamoto K
    Arch Dermatol; 1981 Jun; 117(6):349-53. PubMed ID: 7018404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis.
    Billet SE; Kortuem KR; Gibson LE; El-Azhary R
    Arch Dermatol; 2008 Jun; 144(6):774-8. PubMed ID: 18559768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug induced linear IgA disease with unusual features: Koebner phenomenon, local insulin sensitivity and annular blister of the nipples.
    Rashid Dar N; Raza N
    Acta Dermatovenerol Croat; 2008; 16(4):215-7. PubMed ID: 19111146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear IgA bullous dermatosis induced by atorvastatin.
    König C; Eickert A; Scharfetter-Kochanek K; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2001 Apr; 44(4):689-92. PubMed ID: 11260550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear IgA disease and ulcerative colitis.
    De Simone C; Guerriero C; Pellicano R
    Eur J Dermatol; 1998; 8(1):48-50. PubMed ID: 9649655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced linear IgA bullous dermatosis.
    Navi D; Michael DJ; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathologic studies of adult linear IgA bullous dermatosis.
    Flotte TJ; Olbricht SM; Collins AB; Harrist TJ
    Arch Pathol Lab Med; 1985 May; 109(5):457-9. PubMed ID: 3885903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.
    Plunkett RW; Chiarello SE; Beutner EH
    J Am Acad Dermatol; 2001 Nov; 45(5):691-6. PubMed ID: 11606917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Waldman MA; Black DR; Callen JP
    Clin Exp Dermatol; 2004 Nov; 29(6):633-6. PubMed ID: 15550142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Verapamil-induced linear IgA disease mimicking toxic epidermal necrolysis].
    Schroeder D; Saada D; Rafaa M; Ingen-Housz-Oro S; Valeyrie-Allanore L; Sigal ML
    Ann Dermatol Venereol; 2011; 138(4):302-6. PubMed ID: 21497257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naproxen-associated linear IgA bullous dermatosis: case report and review.
    Bouldin MB; Clowers-Webb HE; Davis JL; McEvoy MT; Davis MD
    Mayo Clin Proc; 2000 Sep; 75(9):967-70. PubMed ID: 10994833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized linear IgA dermatosis induced by UV light-treatment for herpes zoster.
    He C; Xu H; Xiao T; Geng L; Chen HD
    Int J Dermatol; 2007 May; 46(5):500-2. PubMed ID: 17472682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.